Income Statement for the Period, Consolidated (IFRS)
Gross Sales Revenues
10
0
CAGR
-1,0%
4Q12
8.99B
8987704
4Q13
10.3B
10320997
4Q14
10.8B
10843796
4Q15
10.4B
10449129
4Q16
8.62B
8619629
Assets, Consolidated (IFRS)
Total Assets
10
0
CAGR
-2,1%
4Q13
58.2B
58215040
4Q14
63.0B
63042330
4Q15
70.1B
70094709
4Q16
54.6B
54635141
Liabilities, Consolidated (IFRS)
Consolidated Stockholders' Equity
3
0
CAGR
-8,8%
4Q13
32.0B
32020757
4Q14
33.3B
33254534
4Q15
32.0B
31970383
4Q16
24.3B
24274653